Literature DB >> 11590913

Effects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo.

D Y Cha1, I K Song, G S Lee, O S Hwang, H J Noh, S D Yeo, D W Shin, Y H Lee.   

Abstract

Although some reports have been published on the protective effect of antibodies to Toxoplasma gondii surface membrane proteins, few address the inhibitory activity of antibodies to dense granular proteins (GRA proteins). Therefore, we performed a series of experiments to evaluate the inhibitory effects of monoclonal antibodies (mAbs) to GRA proteins (GRA2, 28 kDa; GRA6, 32 kDa) and surface membrane protein (SAG1, 30 kDa) on the invasion of T. gondii tachyzoites. Passive immunization of mice with one of three mAbs following challenge with a lethal dose of tachyzoites significantly increased survival compared with results for mice treated with control ascites. The survival times of mice challenged with tachyzoites pretreated with anti-GRA6 or anti-SAG1 mAb were significantly increased. Mice that received tachyzoites pretreated with both mAb and complement had longer survival times than those that received tachyzoites pretreated with mAb alone. Invasion of tachyzoites into fibroblasts and macrophages was significantly inhibited in the anti-GRA2, anti-GRA6 or anti-SAG1 mAb pretreated group. Pretreatment with mAb and complement inhibited invasion of tachyzoites in both fibroblasts and macrophages. These results suggest that specific antibodies to dense-granule molecules may be useful for controlling infection with T. gondii.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590913      PMCID: PMC2721072          DOI: 10.3347/kjp.2001.39.3.233

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  21 in total

1.  Detection and characterization of excretory/secretory proteins from Toxoplasma gondii by monoclonal antibodies.

Authors:  E S Son; H W Nam
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

2.  T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of the fine antigenic specificity of the clones and implications for vaccine development.

Authors:  I Prigione; P Facchetti; L Lecordier; D Deslée; S Chiesa; M F Cesbron-Delauw; V Pistoia
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

3.  Prevention of peroral and congenital acquisition of Toxoplasma gondii by antibody and activated macrophages.

Authors:  P Eisenhauer; D G Mack; R McLeod
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii.

Authors:  S D Sharma; F G Araujo; J S Remington
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

5.  Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase.

Authors:  C Dando; K E Gabriel; J S Remington; S F Parmley
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Intracellular trafficking of dense granule proteins in Toxoplasma gondii and experimental evidences for a regulated exocytosis.

Authors:  I Coppens; M Andries; J L Liu; M F Cesbron-Delauw
Journal:  Eur J Cell Biol       Date:  1999-07       Impact factor: 4.492

7.  A role for B cells in the development of T cell helper function in a malaria infection in mice.

Authors:  J Langhorne; C Cross; E Seixas; C Li; T von der Weid
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

8.  Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.

Authors:  J R Mineo; R McLeod; D Mack; J Smith; I A Khan; K H Ely; L H Kasper
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

9.  Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.

Authors:  A M Johnson; P J McDonald; S H Neoh
Journal:  J Protozool       Date:  1983-05

10.  Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.

Authors:  S Chamberland; H A Kirst; W L Current
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

View more
  8 in total

Review 1.  GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane.

Authors:  Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

2.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

3.  Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites.

Authors:  Yong-Feng Fu; Meng Feng; Kenji Ohnishi; Tamon Kimura; Johbu Itoh; Xun-Jia Cheng; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 4.  Recent advances in Toxoplasma gondii immunotherapeutics.

Authors:  Sherene Swee-Yin Lim; Rofina Yasmin Othman
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

5.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

6.  A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis.

Authors:  Xiaowei Tian; Hanqi Sun; Meng Wang; Guangmin Wan; Tong Xie; Xuefang Mei; Zhenchao Zhang; Xiangrui Li; Shuai Wang
Journal:  Front Vet Sci       Date:  2022-02-15

7.  Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.

Authors:  Xiao T Ching; Mun Y Fong; Yee L Lau
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

Review 8.  Treatment of toxoplasmosis: Current options and future perspectives.

Authors:  Neda Konstantinovic; Hélène Guegan; Tijana Stäjner; Sorya Belaz; Florence Robert-Gangneux
Journal:  Food Waterborne Parasitol       Date:  2019-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.